1. GBp

    4,064

    Today's change

    -33.00 / -0.81%

    1 year change

    -6.38%

    As of Jun 30 2015 13:30 BST. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. June 21, 2015

    Pharmaceutical pollution in India is bitter pill for Nordea

    The largest investment house in the Nordic region has accused the world’s biggest pharmaceutical companies of ignoring...

  2. June 5, 2015

    Cancer treatment: Healing powers

    It felt more like a gathering of Silicon Valley entrepreneurs than a mainstream medical meeting. But the 30,000 delegates at...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Combating Cancer

    A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
Search more Special Reports on this topic.

  1. June 3, 2015

    The unhealthily high price of cancer drugs

    If the worst happens, there is one comfort: this is the best time in history to contract cancer. You stand a better chance...

  2. June 2, 2015

    AstraZeneca chief warns UK ‘falling behind’ in cancer care

    AstraZeneca’s chief executive has warned that the UK is “falling behind” in cancer care and questioned the government’s...

  3. June 2, 2015

    Financial pressure is a mind-altering drug for NHS and AstraZeneca

    The splendour of the National Health Service is illustrated by the redundancy of Breaking Bad’s plot arc in a British...

  4. May 31, 2015

    Clinical trials show cancer drug combo boosts survival rate

    A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

  5. May 29, 2015

    Doctors hail new front in fight against cancer

    A novel class of drugs that turn the body into a weapon against tumours are set to be given to 60,000 of the sickest lung...

  6. May 29, 2015

    Novel cancer drugs tipped to boost drug sales

    In 1947, Sidney Farber, a pathologist working in a tiny hospital laboratory in Boston, gave an experimental cocktail of...

  7. May 28, 2015

    Fifa: Grand Theft Football

    Video game review Fifa 2015 Soccer (Foreign Corrupt Practices Edition) for Xbox and PS3, £22 from Esoteric Arts EA has...

  8. May 26, 2015

    Pfizer and AstraZeneca: one year after deal that never was

    It is a year this week since Pfizer admitted defeat in its £69.4bn hostile pursuit of AstraZeneca. The factors that led the...

  9. May 26, 2015

    First Solar’s shine dims on downgrade

    First Solar was one of the worst-performing stocks on the S&P 500 after analysts at RBC Capital Markets projected “flattish...

  10. May 17, 2015

    Fund houses back the boss too often

    BlackRock, Aberdeen and Schroders are among six asset managers ShareAction, the investor rights charity, has accused of...

  11. May 15, 2015

    The drugs to watch in fight against cancer

    About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society of...

  12. May 8, 2015

    Boardroom trades, May 9

    The board table at AstraZeneca is chock-full of non-executives: only two executive directors have places on the board at the...

  13. May 5, 2015

    Global spending on cancer drugs surges to $100bn

    Global annual spending on cancer drugs has hit $100bn for the first time as the pharmaceuticals industry prepares to launch...

  14. April 26, 2015

    No end in sight to wave of pharma dealmaking

    Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than the...

  15. April 24, 2015

    AstraZeneca forced to defend cancer drug deal with Celgene

    AstraZeneca will receive a $450m windfall from Celgene as part of a partnership to develop cancer drugs together — but the...

  16. April 13, 2015

    Biotech: Making sense of the science

    It was supposed to be a wonder drug. Provenge promised to turn the body’s immune system into a weapon against disease,...

  17. April 7, 2015

    Big pharma turns to small biotechs for edge in cancer treatment

    Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category of...

  18. April 2, 2015

    Pascal Soriot takes name off list of Tory business supporters

    The chief executive of AstraZeneca has removed his name from the list of business leaders backing Conservative party...

  19. March 29, 2015

    City accused of failing to back life sciences sector

    One of Britain’s top scientists has accused the City of London of failing to offer the kind of support to the UK life...

  20. March 26, 2015

    Drugs companies unite to mine genetic data

    Several of the world’s biggest pharmaceuticals companies have formed a partnership with Genomics England in the first step...

  21. March 26, 2015

    Jon Moulton-backed biotech company to list on Aim

    A Liverpool-based biotech company, backed by venture capitalist Jon Moulton, will float in London on Friday in a sign of...

  22. March 15, 2015

    Pharma sector hails ‘sea change’ in heart disease treatment

    The pharmaceuticals industry has hailed an impending “sea change” in the treatment of heart disease as it gears up to launch...

  23. March 12, 2015

    AstraZeneca leads the way in drugmaker jump

    Another surge higher for drug stocks put AstraZeneca at the top of the FTSE 100 leaderboard. The last-minute counterbid for...

  24. March 6, 2015

    Going the extra mile to win a $21bn deal

    The Pharmacyclics executives could hardly believe the turn of events. As they gathered on Wednesday at the drugmaker’s law...

  25. February 27, 2015

    AstraZeneca carves out antibiotic research

    AstraZeneca is to set up a standalone company to take over its research into new antibiotics for gonorrhoea and other...

  26. February 20, 2015

    Week in Review, February 21

    A round up of some of the week’s most significant corporate events and news stories. HSBC hit by Swiss raid HSBC suffered...

  27. February 19, 2015

    Centrica leads FTSE lower after profit fall

    Centrica was the biggest faller on the FTSE 100 on Thursday morning after the gas supplier reported a sharp fall in profit....

  28. February 17, 2015

    AstraZeneca lines up pharma critic for board

    AstraZeneca has nominated to its board a US scientist who has tweeted strongly critical views of the pharmaceuticals...

  29. February 17, 2015

    London stocks hit by Greece woes

    London stocks made a weaker start on Tuesday as talks between Greece and the European Union broke down, creating a damper on...

  30. February 16, 2015

    Compound sharing boosts drugs success

    In every science-based industry, the 20th-century model of research and development carried out in closed corporate labs is...

  31. February 16, 2015

    Gene editing comes of healthcare age

    Genetic engineering first became possible with the invention of “recombinant DNA” technology in the early 1970s. But for...

  32. February 10, 2015

    Healthcare: The race to cure rising drug costs

    Since contracting hepatitis C 25 years ago, Lucinda Porter’s biggest fear has been that she would infect someone else with...

  33. February 6, 2015

    Pharma takes a dose of sense from the deals doctor

    Taking the wrong combination of drugs can have serious side effects. The same goes for pharmaceuticals dealmaking. Mix up...

  34. February 5, 2015

    Pfizer: only in America

    M&A begins at home for Pfizer. It may not end there. Jilted by AstraZeneca in 2014 — it had hoped to “invert” into its...

  35. February 5, 2015

    AstraZeneca / Sanofi: inversion

    It looks upside down. Two big European pharma groups reported 2014 results on Thursday. AstraZeneca clocked in with a 3 per...

  36. February 5, 2015

    Pfizer’s $17bn Hospira buy could lead to break-up

    Is Pfizer going through a slow-motion break-up? The prevailing view among many analysts on Thursday was Yes, after it...

  37. February 5, 2015

    Lazard’s M&A advisory revenues top $1bn

    Lazard’s merger and acquisition advisory revenues topped $1bn for the first time in the US investment bank’s history in...

  38. February 5, 2015

    AstraZeneca to pay $600m for Actavis respiratory drugs

    AstraZeneca has agreed to pay $600m for the rights to Actavis’s branded respiratory drugs business in North America as it...

Search for AstraZeneca PLC and